Caprion Biosciences

Caprion Biosciences

2019 exit: Global leader in cancer immunotherapy laboratory services

Investment
July 2016
View case study
Quotient Sciences

Quotient Sciences

2019 exit: Globally differentiated pharmaceutical drug development service provider

Investment
December 2015
View case study
BioAgilytix

BioAgilytix

2021 exit: Global industry leader in analytical testing for biologic drug development

Investment
February 2019
View case study